📣 Notice: Short Maintenance Tonight (May 19th)
Due to increasing user numbers, we’re upgrading our servers this evening. StocksGuide will be unavailable for about 5–10 minutes between 4:00 PM and 5:00 PM (EDT / New York time). Afterwards, you’ll continue to benefit from fast and stable site performance. Thank you for your understanding! Your StocksGuide Team

$4.51
7.13% today
NYSE, May 19, 08:21 pm CET
ISIN
US80880W1062
Symbol
SCLX
Sector
Industry

Scilex Stock price

$4.21
-1.91 31.21% 1M
-18.02 81.06% 6M
-10.71 71.79% YTD
-26.24 86.17% 1Y
-352.79 98.82% 3Y
-340.54 98.78% 5Y
-340.54 98.78% 10Y
NYSE, Closing price Fri, May 16 2025
+0.09 2.18%
ISIN
US80880W1062
Symbol
SCLX
Sector
Industry

Key metrics

Market capitalization $29.27m
Enterprise Value $72.28m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 4.51
EV/Sales (TTM) EV/Sales 1.43
P/S ratio (TTM) P/S ratio 0.58
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 7.79%
Revenue (TTM) Revenue $50.71m
EBIT (operating result TTM) EBIT $-94.32m
Free Cash Flow (TTM) Free Cash Flow $16.03m
Cash position $5.80m
EPS (TTM) EPS $-15.64
P/E forward negative
P/S forward 0.20
EV/Sales forward 0.49
Short interest 5.80%
Show more

Is Scilex a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

Scilex Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Scilex:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Scilex:

Hold
100%

Financial data from Scilex

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
51 51
8% 8%
100%
- Direct Costs 18 18
9% 9%
36%
32 32
20% 20%
64%
- Selling and Administrative Expenses 114 114
2% 2%
224%
- Research and Development Expense 8.99 8.99
31% 31%
18%
-90 -90
11% 11%
-178%
- Depreciation and Amortization 4.02 4.02
7% 7%
8%
EBIT (Operating Income) EBIT -94 -94
11% 11%
-186%
Net Profit -75 -75
31% 31%
-147%

In millions USD.

Don't miss a Thing! We will send you all news about Scilex directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Scilex Stock News

Neutral
GlobeNewsWire
4 months ago
PALO ALTO, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, in neurodegenerative and cardi...
Neutral
GlobeNewsWire
4 months ago
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiome...
Neutral
GlobeNewsWire
4 months ago
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiome...
More Scilex News

Company Profile

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Head office United States
CEO Jaisim Shah
Employees 115
Founded 2020
Website www.scilexholding.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today